Nvidia’s impact on health care
Plus: five more states join the FTC's Hims suit, the FDA adds vision warnings to GLP-1s, and Rounds Season 2 premieres.
Christina Farr and Ruth Reader
7 min read
Know what’s moving healthtech—and why it matters.
Independent reporting and sharp analysis from Christina Farr and other healthcare insiders.
The Latest
View allFour Questions with Kimberly Powell
Christina Farr
4 min read
Tech
Premium
HHS to wrangle the state AI sandboxes
Ruth Reader
9 min read
Virtual Care
Premium
What patients want from virtual care, and what operators should do about it
Keaton Bedell
9 min read
webinar
Premium
AMA with Doximity CEO Jeff Tangney
Oura to buy Counsel Health
Ruth Reader
2 min read
Trusted by leading organizations
Sessions
Live conversations with the leaders behind healthcare’s biggest ideas.
Upcoming
Reg. Closed
Past Event
Premium
AMA with Doximity CEO Jeff Tangney
Join Doximity CEO Jeff Tangney for a live Q&A on where clinicians are finding value with AI, how Doximity has evolved, and building a company from zero to IPO.
Upcoming
Reg. Closed
Past Event
Premium
Office Hours
A live Q&A with Christina Farr and Ruth Reader, exclusively for Second Opinion Premium members. Thursday, November 19, 1:30–2:30 p.m. ET / 10:30–11:30 a.m. PT.
A bit about Second Opinion
Healthcare is complicated. The incentives are strange, the acronyms are endless, and the stakes are enormous.
At Second Opinion, we try to make sense of it. We cover the business of healthcare, from policy shifts and startup bets to the capital and ideas shaping the future of care.
I'm Christina Farr. I've spent more than a decade covering healthcare and now invest in the industry as a General Partner at Scrub Capital.
If you care about where healthcare is headed, you're in the right place. We're glad you're here.